Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation ConditioningHematopoietic Stem Cell MobilizationHematologic NeoplasmsMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Graft vs Host DiseaseBlood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsTreatment OutcomeBusulfanBone Marrow TransplantationGraft SurvivalLymphoma, Non-HodgkinHematopoietic Stem CellsEtoposideRecurrenceThiotepaRemission InductionAntineoplastic Agents, AlkylatingCytophagocytosisCarmustineIfosfamideSalvage TherapyRetrospective StudiesVincristineAmyloidosisCytarabineStem CellsHematopoiesisTransplantation ChimeraHodgkin DiseaseCord Blood Stem Cell TransplantationSurvival RateDisease-Free SurvivalTissue DonorsNeoplasmsGraft vs Leukemia EffectTime FactorsWhole-Body IrradiationLeukemiaSurvival AnalysisInfectionHistocompatibilityLymphoma, T-CellDoxorubicinHistocompatibility TestingPOEMS SyndromePlatelet CountImmunosuppressive AgentsFollow-Up StudiesTransplantation, IsogeneicPrednisoneLeukemia, Myeloid, AcuteCarboplatinVidarabineDexamethasoneProspective StudiesBlood Cell CountRecombinant ProteinsCytomegalovirus InfectionsAntineoplastic AgentsBone Marrow PurgingLymphomaGraft vs Tumor EffectBlood CellsFatal OutcomeFeasibility StudiesMyelodysplastic SyndromesAnemia, AplasticImmunophenotypingBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveT-LymphocytesLymphocyte DepletionLiver TransplantationHematologic DiseasesAcute DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensLeukocytes, MononuclearOpportunistic InfectionsImmunosuppressionCyclosporineBone MarrowHistiocytosis, Non-Langerhans-CellLivedo ReticularisPrognosisBlood DonorsBreast Neoplasms